FDA Warning Letter — Central Coast Multispecialty Medical Group, Inc.

Case 722521 — FEI 3003969216

The FDA took a Warning Letter action against Central Coast Multispecialty Medical Group, Inc. on January 29, 2026 (Monterey, CA). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Central Coast Multispecialty Medical Group, Inc.
Date
January 29, 2026
Fiscal Year
2026
Product Type
Biologics
Center
CBER
Location
Monterey, CA (United States)